Percutaneous Skeletal Fixation of Painful Subchondral Bone Marrow Edema Utilizing an Injectable, Synthetic, Biocompatible Hyaluronic Acid–Based Bone Graft Substitute

Subchondral bone marrow edema (SBME) represents a pathologic alteration of subchondral bone. A strong correlation exists between its presence and the progression of osteoarthritis. Very few treatment options exist between the spectrum of conservative management and the definitive treatment of total...

Descripción completa

Detalles Bibliográficos
Autores principales: Stark, Michael, DeBernardis, Dennis, McDowell, Chris, Ford, Elizabeth, McMillan, Sean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Technical Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695546/
https://www.ncbi.nlm.nih.gov/pubmed/33294321
http://dx.doi.org/10.1016/j.eats.2020.07.005
Descripción
Sumario:Subchondral bone marrow edema (SBME) represents a pathologic alteration of subchondral bone. A strong correlation exists between its presence and the progression of osteoarthritis. Very few treatment options exist between the spectrum of conservative management and the definitive treatment of total knee arthroplasty (TKA). Tactoset® is an injectable synthetic, biocompatible hyaluronic acid–based bone graft substitute that allows for a minimally invasive treatment for painful SBME via percutaneous skeletal fixation (PSF). We present the technique of PSF using Tactoset.

Ejemplares similares